The EU Court of First Instance states that a Commission’s letter does not produce a legally binding effect and therefore cannot be challenged by drug companies (Nefarma)
Case T-113/89
Nederlandse Associatie van de Farmaceutische Industrie 'Nefarma' and Bond van Groothandelaren in het Farmaceutische Bedrijf
v
Commission of the European Communities*
A letter addressed to the authorities of a Member State by a Member of the Commission which merely represents an initial evaluation, by
Access to this article is restricted to subscribers
Already Subscribed? Sign-in